Used primarily in pharmaceutical research as a key intermediate in the synthesis of GABA receptor modulators. Its structural framework allows for selective binding to central nervous system targets, making it valuable in developing treatments for neurological disorders such as epilepsy, anxiety, and insomnia. The compound's rigid polycyclic backbone enhances metabolic stability and bioavailability in drug candidates. It is also explored in the design of novel anxiolytics with reduced sedative effects compared to traditional benzodiazepines.